ICMR

Shfaaqna Health: One in seven stroke patients in India falls in the 18-44 age group, while two in five reach hospital more than 24 hours after the onset of symptoms, according …

Shafaqna Health: With over 25.44 lakh people living with HIV in India, the Indian Council of Medical Research-National Institute of Epidemiology (ICMR-NIE) surveillance has stated that four southern states and a …

Shafaqna India: A 10-month-old child in Assam has been diagnosed with human metapneumovirus (HMPV), marking the first case of the season, officials confirmed on Saturday. The child, admitted to Assam Medical …

Shafaqna India: The Indian Council of Medical Research (ICMR) has identified two cases of Human Metapneumovirus (HMPV) in Karnataka through routine surveillance for respiratory viral pathogens, the Union Health Ministry announced …

People in the 18-59 age group will get free precaution doses of the Covid vaccine at government vaccination centres under a 75-day special drive likely to begin from July 15, …

Contacts of confirmed Covid cases do not need to get tested unless identified as “high risk” based on age or comorbidities, according to a new government advisory. The ICMR Advisory …

Although Omicron is predicted to cause more breakthrough infections, it is “impractical and impossible” that it will infect huge numbers in India, and result in severe disease and death, if …

Although Omicron is predicted to cause more breakthrough infections, it is “impractical and impossible” that it will infect huge numbers in India, and result in severe disease and death, if …

The Indian Council of Medical Research on Sunday revealed that mixing and matching of vaccines Covishield and Covaxin can yeild better results against Covid-19. “Immunization with combination of an adenovirus …

The Union Health Ministry has appealed to all the states and Union Territories (UTs) to declare mucormycosis or black fungus as a notifiable disease under the Epidemic Disease Act 1897. …

Days after the ICMR announced indigenous Covaxin worked against the Sars-Cov2 double mutant 617, the US too has endorsed its effectiveness. The mutant, as per the World Health Organisation (WHO), …

Ahead of further expansion of the COVID inoculation plan to cover all adults from May 1, data show negligible infections after the first and the second doses of India made …

More than 21,000 people tested positive for COVID-19 after taking the first dose of either Covishield or Covaxin, while over 5,500 contracted the infection after taking the second dose, the …

With plummeting Covid-19 infections starting to trigger complacency among people, the chief of epidemiology at the ICMR has warned against prevention-fatigue saying a resurgence of the disease cannot be ruled …

Made-in-India Covaxin works against the Covid strain circulating in India as well as the new UK mutant, a research has shown. The landmark peer-reviewed research by ICMR scientists shows the …

India’s first indigenous vaccine against COVID-19, Covaxin, showed enhanced immune response without any serious side effects in the participants enrolled for the phase 1 trials, according to the results published …

The Indian Council of Medical Research (ICMR) has said that the Indian vaccine against Covid-19, Covaxin, has drawn global attention. In a tweet, the ICMR said, “India’s indigenous vaccine against …

Phase three trials of India’s first vaccine against COVID-19 has started in what is the largest human trials to be conducted with about 26,000 participants, Bharat Biotech announced on Monday. …